CJC-1295 without DAC 5mg + Ipamorelin 5mg

CJC-1295 (No DAC) + Ipamorelin – 5mg / 5mg Blend

Overview

CJC-1295 (No DAC) and Ipamorelin are synthetic peptides commonly studied together for their complementary effects on growth hormone signaling. This blend is widely used in research focused on endocrine function and pulsatile growth hormone release.

Mechanism of Action

CJC-1295 (No DAC) is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone in a controlled, natural-like pulse. Ipamorelin is a selective ghrelin receptor agonist that promotes growth hormone release without significantly affecting other hormones.

Together, they may produce a synergistic effect by enhancing both the signaling and release of growth hormone.

Research Applications

• Growth hormone secretion studies

• Metabolic function research

• Muscle and tissue response

• Recovery and regenerative processes

Potential in Scientific and Medical Research

This peptide combination is being studied for its potential role in hormone regulation, tissue repair, and metabolic health. Ongoing research continues to explore its broader applications.

Product Details

• Contents: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin

• Form: Lyophilized powder

• Storage: Store in a cool, dry place. Refrigerate 2°C to 8°C (36°F to 46°F)  after reconstitution

Important Disclaimer

This product is intended strictly for laboratory research and development purposes only. It is not for human or animal consumption. These compounds are not intended to diagnose, treat, cure, or prevent any disease.

This product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). All purchasers are responsible for complying with applicable laws and regulations.